✦ LIBER ✦

A Pilot Study of Dose Intense Doxorubicin and Cyclophosphamide Followed by Infusional Paclitaxel in High-Risk Primary Breast Cancer

✍ Scribed by Jo Anne Zujewski; Jennifer Eng-Wong; Joyce O'Shaughnessy; David Venzon; Catherine Chow; David Danforth; David R. Kohler; Georgia Cusack; David Riseberg; Kenneth H. Cowan

Book ID: 111550480
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 377 KB
Volume: 81
Category: Article
ISSN: 0167-6806
DOI: 10.1023/a:1025421416674

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Pilot Study of Continuous Infusional 5

A Pilot Study of Continuous Infusional 5-Fluorouracil, Doxorubicin and Cyclophosphamide in Breast Cancer

✍ H.J. Mackay; D. Bissett; C. Twelves; P.A. Vasey 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Adjuvant dose-dense doxorubicin plus cyc

Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-densenab-paclitaxel is safe in women with early-stage breast cancer: a pilot study

✍ Nicholas Robert; Lea Krekow; Chris Stokoe; Alicia Clawson; Jose Iglesias; Joyce 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 199 KB

A Feasibility Study of Bevacizumab plus

A Feasibility Study of Bevacizumab plus Dose-Dense Doxorubicin–Cyclophosphamide (AC) Followed by Nanoparticle Albumin–Bound Paclitaxel in Early-Stage Breast Cancer

✍ Sikov, W.M.; Sinclair, N. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

A Phase I Toxicity and Feasibility Trial

A Phase I Toxicity and Feasibility Trial of Sequential Dose-Dense Induction Chemotherapy with Doxorubicin, Paclitaxel, and 5-Fluorouracil Followed by High Dose Consolidation for High-Risk Primary Breast Cancer

✍ Leisha A. Emens; M. John Kennedy; John H. Fetting; Nancy E. Davidson; Elizabeth 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 150 KB

Long-term assessment of cardiac function

Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer

✍ Maysa M. Abu-Khalaf; Vinni Juneja; Gina G. Chung; Michael P. DiGiovanna; Rebecca 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 209 KB

High-dose doxorubicin, etoposide, and cy

High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer

✍ George Somlo; James H. Doroshow; Stephen J. Forman; Lucille A. Leong; Kim A. Mar 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 780 KB